Cell-Based Screening: Accelerating Therapeutic Development

When developing therapeutics, physiologically relevant cell-based assays are crucial. Historically, these assays have relied on stable cell lines, which can be expensive and time-consuming to develop. Additionally, traditional methods like phage display for protein or cell-based immunotherapeutic discovery often lead to bottlenecks due to long selection cycles.

This webinar explores how advanced transient transfection technology can accelerate therapeutic development by enabling faster and more flexible cell-based screening assays. You'll learn about the benefits and challenges of cell-based assays and discover how optimized assay development is possible. The discussion will also cover mammalian display screening for antibody and cell therapy discovery, providing valuable insights from case studies and real user datasets. Tune in to understand how these advancements can streamline your research.